Back to search

Article

PILRA regulates microglial immunometabolism to reduce disease pathology as a candidate therapeutic target for Alzheimer’s disease

2025-03-12

Abstract excerpt

<title>Abstract</title> <p> The Alzheimer’s disease (AD) genetic landscape identified microglia as a key disease-modifying cell type. A known AD protective variant in paired immunoglobulin-like type 2 receptor alpha (PILRA), shown to reduce risk in APOE4 carriers, is enriched in a cohort of healthy centenarians; however, mechanisms underlying protective effects in microglia are undefined. Here we identify biolog...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
02754854-4d1e-57cc-9f3b-b8ab7257148f
DOI
10.21203/rs.3.rs-3954863/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PILRA regulates microglial immunometabolism to reduce disease pathology as a candidate therapeutic target for Alzheimer’s diseaseDOI 10.21203/rs.3.rs-3954863/v2
Select a neighboring publication to make it the new centre.